Skip to main content
Premium Trial:

Request an Annual Quote

No Longer Just Google-Backed, 23andMe Attracts $22M from J&J, Other Investors

Premium

Originally published Nov. 9.

23andMe added Johnson & Johnson Development Corporation to its investors this week as it raised more than $22 million in a Series C financing round.

Existing investors Google and New Enterprise Associates also participated in the round.

In June 2009, the firm received a $2.6 million Series B investment from Google, which back in 2007 helped launch 23andMe with $3.9 million in Series A funding. The firm also has received financing from Google co-founder Sergey Brin, who is married to 23andMe co-founder and CEO Anne Wojcicki.

“We believe this round of financing will help us achieve our goal of dramatically accelerating the pace of research and could ultimately make health care research and health care delivery more efficient,” Wojcicki said in a statement.

Simultaneously, with this infusion of cash, 23andMe is looking to fill open positions within the firm. Jobs are available within the company in engineering, finance, human resources, legal, operations, product management, research, and science writing.

In October 2009, 23andMe laid off some of its staff in response to the weak economy. At the time, the company did not say how many people it had let go.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.